Literature DB >> 22729141

Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification.

Arne Warth1, Judith Cortis, Ludger Fink, Annette Fisseler-Eckhoff, Helene Geddert, Thomas Hager, Klaus Junker, Gian Kayser, Julia Kitz, Florian Länger, Alicia Morresi-Hauf, German Ott, Iver Petersen, Albrecht Stenzinger, Alex Soltermann, Saskia Ting, Verena Tischler, Ekkehard Vollmer, Philipp A Schnabel, Wilko Weichert.   

Abstract

The International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS) proposed a classification for lung adenocarcinomas (ADC) based on the predominant growth pattern. This classification has been shown to have prognostic and maybe even predictive impact. However, until now, the reproducibility of this classification has not been sufficiently demonstrated. Digital images of 40 selected ADC cases were shown twice to members of the Pulmonary Pathology Working Group of the German Society of Pathology. Each time a teledialogue-based survey on the classification was performed. Between the voting procedures, salient features of the novel classification were presented and discussed in detail by its members. The mean percentages of consensual votes per pattern ranged between 59.6 and 75 %, with lepidic and solid being the pattern with the most discordant and concordant votes, respectively. The other patterns ranged in between (papillary 65.8 %; acinar 67.8 %; micropapillary 74.2 %). The extent of disagreement decreased after the educational session. This decrease, however, was heterogeneous for the different patterns with acinar being the pattern with the strongest improvement. The overall number of abstentions decreased significantly after the educational session (p < 0.001) as well. The IASLC/ATS/ERS classification of lung ADC can be applied with reasonable consensus even for difficult cases in a nationwide context. The reproducibility evidently improves following educational sessions, even among experienced lung pathologists. Worldwide harmonization is clearly the next step on the way to a clinically meaningful, internationally accepted use of this novel prognostic and potentially predictive tool in lung pathology.

Entities:  

Mesh:

Year:  2012        PMID: 22729141     DOI: 10.1007/s00428-012-1263-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  14 in total

1.  Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas.

Authors:  Arne Warth; Albrecht Stenzinger; Ann-Christin von Brünneck; Benjamin Goeppert; Judith Cortis; Iver Petersen; Hans Hoffmann; Philipp A Schnabel; Wilko Weichert
Journal:  Eur Respir J       Date:  2012-03-09       Impact factor: 16.671

Review 2.  The evolving role of histology in the management of advanced non-small-cell lung cancer.

Authors:  Corey J Langer; Benjamin Besse; Antonio Gualberto; Elizabeth Brambilla; Jean-Charles Soria
Journal:  J Clin Oncol       Date:  2010-11-15       Impact factor: 44.544

Review 3.  Grading and scoring in histopathology.

Authors:  S S Cross
Journal:  Histopathology       Date:  1998-08       Impact factor: 5.087

4.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

5.  The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

Authors:  Arne Warth; Thomas Muley; Michael Meister; Albrecht Stenzinger; Michael Thomas; Peter Schirmacher; Philipp A Schnabel; Jan Budczies; Hans Hoffmann; Wilko Weichert
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

6.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

7.  A web-based tutorial improves practicing pathologists' Gleason grading of images of prostate carcinoma specimens obtained by needle biopsy: validation of a new medical education paradigm.

Authors:  J D Kronz; M A Silberman; W C Allsbrook; J I Epstein
Journal:  Cancer       Date:  2000-10-15       Impact factor: 6.860

Review 8.  Grading of soft tissue sarcomas: review and update.

Authors:  Jean-Michel Coindre
Journal:  Arch Pathol Lab Med       Date:  2006-10       Impact factor: 5.534

9.  Reproducibility of a histopathologic grading system for adult soft tissue sarcoma.

Authors:  J M Coindre; M Trojani; G Contesso; M David; J Rouesse; N B Bui; A Bodaert; I De Mascarel; A De Mascarel; J F Goussot
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

10.  Histological grading of breast carcinomas: a study of interobserver agreement.

Authors:  P Robbins; S Pinder; N de Klerk; H Dawkins; J Harvey; G Sterrett; I Ellis; C Elston
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

View more
  19 in total

Review 1.  [Lung cancer. Developments, concepts and preview of the new WHO classification].

Authors:  I Petersen; A Warth
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  Pulmonary adenocarcinoma histology.

Authors:  Erik Thunnissen
Journal:  Transl Lung Cancer Res       Date:  2012-12

3.  [Current issues in pulmonary pathology. Report of the working group on pulmonary pathology of the German Society of Pathology].

Authors:  Ph A Schnabel; I Petersen; K Junker
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

4.  Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma.

Authors:  Koji Kameda; Takashi Eguchi; Shaohua Lu; Yang Qu; Kay See Tan; Kyuichi Kadota; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2018-09-07       Impact factor: 15.609

Review 5.  Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).

Authors:  Elizabeth R Tang; Andrew M Schreiner; Bradley B Pua
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 6.  [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].

Authors:  A Warth
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

Review 7.  [Novel morphological and molecular aspects of lung cancer].

Authors:  A Warth; A Stenzinger; W Weichert
Journal:  Pathologe       Date:  2013-09       Impact factor: 1.011

8.  Predominant histologic subtype in lung adenocarcinoma predicts benefit from adjuvant chemotherapy in completely resected patients: discovery of a holy grail?

Authors:  Prudence Anne Russell; Gavin Michael Wright
Journal:  Ann Transl Med       Date:  2016-01

Review 9.  Clinical impact of the new IASLC/ATS/ERS lung adenocarcinoma classification for chest surgeons.

Authors:  Haruhiko Nakamura; Masayuki Takagi
Journal:  Surg Today       Date:  2014-11-23       Impact factor: 2.549

10.  Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

Authors:  Ming-Sound Tsao; Sophie Marguet; Gwénaël Le Teuff; Sylvie Lantuejoul; Frances A Shepherd; Lesley Seymour; Robert Kratzke; Stephen L Graziano; Helmut H Popper; Rafael Rosell; Jean-Yves Douillard; Thierry Le-Chevalier; Jean-Pierre Pignon; Jean-Charles Soria; Elisabeth M Brambilla
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.